Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

441.36 +2.44 (+0.56%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
62 63 Next >
News headline image
3 Magnificent Stocks That Are Screaming Buys in October ↗
These stocks give investors something to yell about -- in a good way. 
Via The Motley Fool
News headline image
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation ↗
These companies are helping change medicine; they could make boatloads of money along the way. 
Via The Motley Fool
News headline image
2 Brilliant Growth Stocks to Invest $2,000 in Right Now ↗
These growth companies are capitalizing on underserved target markets. 
Via The Motley Fool
News headline image
5 Top Stocks for October ↗
Venture into October's investment landscape with our five experts, unveiling opportunities in an uneven market environment. 
Via The Motley Fool
News headline image
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs ↗
The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars. 
Via InvestorPlace
News headline image
The Best Stocks to Invest $5,000 in Right Now ↗
Now is a great time to buy Amazon, Enterprise Products Partners, and Vertex Pharmaceuticals. 
Via The Motley Fool
News headline image
$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Analyst Ratings for Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗
 
Via Benzinga
News headline image
Why Editas Medicine Stock Is Soaring Today ↗
Investors are cheering a big analyst upgrade for the gene-editing stock. 
Via The Motley Fool
News headline image
Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment ↗
The FDA is within three months of making a decision on the first-ever CRISPR-based drug. 
Via Investor's Business Daily
News headline image
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher ↗
These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher. 
Via InvestorPlace
News headline image
Three Of Our Top Picks For Your Healthcare Portfolio ↗
Amidst macro uncertainty, healthcare stocks should outperform. 
Via Talk Markets
News headline image
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher ↗
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio. 
Via InvestorPlace
News headline image
This Is What Whales Are Betting On Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
Price Over Earnings Overview: Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
2 Healthcare Stocks That Could Make You Richer ↗
They've beaten the market before. 
Via The Motley Fool
News headline image
Is NASDAQ:VRTX suited for quality investing? ↗
Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX). 
Via Chartmill
News headline image
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move ↗
Great companies haven't gone anywhere. 
Via The Motley Fool
News headline image
3 Magnificent Growth Stocks to Buy Right Now ↗
If you're looking for growth, these stocks could be just the ticket. 
Via The Motley Fool
News headline image
Meta Stock Leads 5 Names Showing Resilience In Market Downturn ↗
These stocks have held up so far, but patience is key amid the correction. 
Via Investor's Business Daily
News headline image
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years ↗
These stocks are great long-term picks. 
Via The Motley Fool
News headline image
Where Will CRISPR Therapeutics Be in 5 Years? ↗
The company hasn't performed well in the past five years, but things could change. 
Via The Motley Fool
News headline image
2 Top Trends to Invest $500 In Right Now ↗
Early investors in these trends may reap the rewards over time. 
Via The Motley Fool
News headline image
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years ↗
There's no guarantee that any stock will be a millionaire-maker. But the chances for this one look pretty good. 
Via The Motley Fool
News headline image
Looking for Growth? These Companies' Revenue May Skyrocket ↗
Catalysts on the horizon could drive gains in these top stocks. 
Via The Motley Fool
News headline image
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today ↗
The returns are impressive, but will they continue to be so? 
Via The Motley Fool
News headline image
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point? ↗
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions. 
Via Investor's Business Daily
News headline image
3 Top Healthcare Stocks Defying the Bear Market ↗
Revenue at all three companies improved last quarter, and their share prices have followed suit. 
Via The Motley Fool
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.